LeonaBio, Inc.
- LONA
- NASDAQ
- Biotechnology
- Neurodegenerative Therapies
- Small Molecule Drugs
$5.27
Today +1.35%Quote Oct 19, 2026, 01:59 PM UTC
−25.18%over the last month
Max drawdown −58.7%From 1-month high −25.2%3 months −31.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$49.7M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$17.50
+232.1% from here
Floor
$4.77
9.5% below price
Where the price sits
8 analysts
Analyst range, low to high
$15.00$20.00
- Price $5.27
- Resistance $5.49
- Consensus $17.50
Analysts' average target sits about 232% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LONAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
19
Founded
2011